Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel

Prostate cancer (PCa) that progresses after androgen deprivation therapy (ADT) remains incurable. The underlying mechanisms that account for the ultimate emergence of resistance to ADT, progressing to castrate-resistant prostate cancer (CRPC), include those that reactivate androgen receptor (AR), or...

Descripción completa

Detalles Bibliográficos
Autores principales: Labanca, Estefania, Bizzotto, Juan, Sanchis, Pablo, Anselmino, Nicolas, Yang, Jun, Shepherd, Peter D. A., Paez, Alejandra, Antico-Arciuch, Valeria, Lage-Vickers, Sofia, Hoang, Anh G., Tang, Ximing, Raso, Maria Gabriela, Titus, Mark, Efstathiou, Eleni, Cotignola, Javier, Araujo, John, Logothetis, Christopher, Vazquez, Elba, Navone, Nora, Gueron, Geraldine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566229/
https://www.ncbi.nlm.nih.gov/pubmed/34584218
http://dx.doi.org/10.1038/s41388-021-02008-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566229/
https://www.ncbi.nlm.nih.gov/pubmed/34584218
http://dx.doi.org/10.1038/s41388-021-02008-9

Ejemplares similares